Connect with us

Business

Capital keeps flowing into ASX Biotech shares in 2021

Published

on

ADVERTISEMENT

Image source: Getty Images

Investor funds continue flowing into ASX listed biotechnology shares this year, with a total of almost $485 million of capital raised this year to date.

Adding the flurry of initial public offerings (IPO) undertaken in the biotech domain, one…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending